Cureosity ApS: Financial statements 2025
CVR: 43392123
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Cureosity ApS (CVR 43392123) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -143,788 and a net result of DKK -143,816 compared with DKK -9,701 the year before. Equity in the 2025 report amounted to DKK 128,091. The solvency ratio was 50.3%.
- Gross Profit
- DKK -143,788
- Profit/Loss
- DKK -143,816
- Equity
- DKK 128,091
- Total Assets
- DKK 254,478
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -144 t. | -144 t. | 128 t. | - |
| 2024 | - | -12 t. | -10 t. | 271 t. | - |
How creditworthy is Cureosity ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Cureosity ApS has published its annual report for 2024. Gross profit came to DKK -12,437, and the net result was DKK -9,701.
About Cureosity ApS
Cureosity ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Anden udgivelse af software. The management consists of Thomas Fryd Petersen. The company is owned by Fryd Flow Holding ApS and Dalsberg Investments ApS. In 2025, the company reported a gross profit of DKK -143,788 and a net result of DKK -143,816 compared with DKK -9,701 the year before. Equity in the 2025 report amounted to DKK 128,091.